Lenalidomide Zentiva 15 mg cietās kapsulas Letônia - letão - Zāļu valsts aģentūra

lenalidomide zentiva 15 mg cietās kapsulas

zentiva, k.s., czech republic - lenalidomīds - kapsula, cietā - 15 mg

Lenalidomide Zentiva 25 mg cietās kapsulas Letônia - letão - Zāļu valsts aģentūra

lenalidomide zentiva 25 mg cietās kapsulas

zentiva, k.s., czech republic - lenalidomīds - kapsula, cietā - 25 mg

Lenalidomide Norameda 25 mg cietās kapsulas Letônia - letão - Zāļu valsts aģentūra

lenalidomide norameda 25 mg cietās kapsulas

norameda uab, lithuania - lenalidomīds - kapsula, cietā - 25 mg

Lenalidomide Sandoz 2,5 mg cietās kapsulas Letônia - letão - Zāļu valsts aģentūra

lenalidomide sandoz 2,5 mg cietās kapsulas

sandoz d.d., slovenia - lenalidomīds - kapsula, cietā - 2,5 mg

Lenalidomide Sandoz 5 mg cietās kapsulas Letônia - letão - Zāļu valsts aģentūra

lenalidomide sandoz 5 mg cietās kapsulas

sandoz d.d., slovenia - lenalidomīds - kapsula, cietā - 5 mg

Lenalidomide Sandoz 10 mg cietās kapsulas Letônia - letão - Zāļu valsts aģentūra

lenalidomide sandoz 10 mg cietās kapsulas

sandoz d.d., slovenia - lenalidomīds - kapsula, cietā - 10 mg

Lenalidomide Sandoz 15 mg cietās kapsulas Letônia - letão - Zāļu valsts aģentūra

lenalidomide sandoz 15 mg cietās kapsulas

sandoz d.d., slovenia - lenalidomīds - kapsula, cietā - 15 mg

Lenalidomide Sandoz 25 mg cietās kapsulas Letônia - letão - Zāļu valsts aģentūra

lenalidomide sandoz 25 mg cietās kapsulas

sandoz d.d., slovenia - lenalidomīds - kapsula, cietā - 25 mg

Lenalidomide Krka d.d. Novo mesto (previously Lenalidomide Krka) União Europeia - letão - EMA (European Medicines Agency)

lenalidomide krka d.d. novo mesto (previously lenalidomide krka)

krka, d.d., novo mesto  - lenalidomide hydrochloride monohydrate - multiple myeloma; lymphoma, follicular - imūnsupresanti - multiple myelomalenalidomide krka d. novo mesto as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide krka d. novo mesto as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone (see section 4. 2) ir norādīts ārstēšanai pieaugušiem pacientiem ar iepriekš neārstētiem multiplā mieloma, kas nav tiesīgi transplantātu. lenalidomide krka d. novo mesto in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. follicular lymphomalenalidomide krka d. novo mesto in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1 – 3a). multiple myelomalenalidomide krka d. novo mesto as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide krka d. novo mesto as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone (see section 4. 2) ir norādīts ārstēšanai pieaugušiem pacientiem ar iepriekš neārstētiem multiplā mieloma, kas nav tiesīgi transplantātu. lenalidomide krka d. novo mesto in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. follicular lymphomalenalidomide krka d. novo mesto in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1 – 3a).

Lenalidomide Norameda 5 mg cietās kapsulas Letônia - letão - Zāļu valsts aģentūra

lenalidomide norameda 5 mg cietās kapsulas

norameda uab, lithuania - lenalidomīds - kapsula, cietā - 5 mg